ArticleDiagnostics (Basel, Switzerland)2022

Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal.

Hsi-Chen Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.